Breaking News
Subscribe Now 0
🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screener
Try Stock Screener
Close

Lo Funds - Swiss Equity (chf) Md (0P000147KS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
17.048 -0.250    -1.44%
31/10 - Closed. Currency in CHF
  • Morningstar Rating:
  • Total Assets: 215.08M
Type:  Fund
Market:  Luxembourg
Issuer:  Lombard Odier Funds (Europe) SA
ISIN:  LU1079728462 
Asset Class:  Equity
Lombard Odier Funds Swiss Equity (CHF) MD 17.048 -0.250 -1.44%

0P000147KS Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Lombard Odier Funds Swiss Equity (CHF) MD (0P000147KS) fund. Our Lombard Odier Funds Swiss Equity (CHF) MD portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 0.260 0.260 0.000
Stocks 99.740 99.740 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 18.357 18.229
Price to Book 3.338 3.267
Price to Sales 2.386 2.058
Price to Cash Flow 14.070 13.888
Dividend Yield 2.681 2.890
5 Years Earnings Growth 7.860 9.221

Sector Allocation

Name  Net % Category Average
Healthcare 33.770 30.300
Financial Services 17.730 19.997
Industrials 15.820 16.119
Consumer Defensive 10.740 13.989
Basic Materials 10.300 8.315
Consumer Cyclical 6.890 5.460
Technology 2.380 3.880
Utilities 1.460 1.028
Real Estate 0.900 1.883

Region Allocation

  • Europe Developed
  • Developed Markets

Top Holdings

Number of long holdings: 39

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Nestle CH0038863350 9.71 80.82 -1.17%
  Novartis CH0012005267 9.38 93.98 -1.67%
  Roche Holding Participation CH0012032048 9.32 268.30 -1.47%
  UBS Group CH0244767585 5.55 27.39 +1.86%
  Alcon CH0432492467 5.28 80.00 +0.88%
  ABB CH0012221716 4.47 49.47 +2.51%
  Lonza Group CH0013841017 4.43 543.60 +0.22%
  Richemont CH0210483332 4.21 124.15 -0.68%
  Zurich Insurance Group CH0011075394 4.16 517.20 +0.90%
  Holcim CH0012214059 4.05 87.76 +1.64%

Top Equity Funds by Lombard Odier Funds (Europe) SA

  Name Rating Total Assets YTD% 3Y% 10Y%
  Lombard Odier Global Prestige P Acc 812.32M 10.88 2.54 8.35
  LombardOdierEuroHiCnvctnSysH CHF RD 175.05M 2.15 -0.42 -
  LombardOdierEuroHiCnvctnSysH CHF PA 175.05M 2.76 0.38 -
  LombardOdierEurHiCnvctnSys H CHF MA 175.05M 3.28 1.06 -
  LombardOdierEuro HiCnvctnSysHCHF NA 175.05M 3.41 1.23 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P000147KS Comments

Write your thoughts about Lo Funds - Swiss Equity (chf) Md
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email